Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Herceptin
(trastuzumab)Orphan drugstandardGenentech, Inc.
HER2/neu Receptor Antagonist [EPC]
12.1 Mechanism of Action The HER2 (or c-erbB2) proto-oncogene encodes a transmembrane receptor protein of 185 kDa, which is structurally related to th...
Jeremy L Davis, M.D.
National Cancer Institute (NCI)
Andrew M Blakely, M.D., STNA
National Cancer Institute (NCI)
📍 COLUMBUS, OH
David Kelsen, MD, MD
Memorial Sloan Kettering Cancer Center
📍 NEW YORK, NY
Bryson W Katona, MD, PhD
University of Pennsylvania
📍 PHILADELPHIA, PA
Raymond Kim, MD
University Health Network, Toronto
Massimiliano di Pietro, MD
MRC Cancer Unit.University of Cambridge.